Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Premixed Protamine Recombinant Human Insulin 30R vs NovoMix 30R in Diabetes
CTR20210530Phase 3Completed
- Sponsor
- Huisheng Biopharmaceutical
- Start
- Apr 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of biphasic human insulin in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM), sponsored by Huisheng Biopharmaceutical. Started Apr 2021; status: completed.
02
Drugs
biphasic human insulin
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20210530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210530.